RxDoctor Payments Data

Grant Chen, MD

Pain Medicine · Houston, TXNPI 1548555469

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $104,938 of the $174,595 with a category attached, or 60.1%. SPR Therapeutics, Inc accounts for 89.9% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $61,730, more than ten times the $216 reported in 2019. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$174,595in general payments, 2019–2025

Across 286 payments — averaging $610.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$157K
  • Stratus Medical, LLC$6K
  • Medtronic$3K
  • Si-bone, Inc.$2K
  • Stryker$1K
  • Abbott$837
  • plus $3K from 18 others

What the payments were for

  • Consulting fees$104,93860%
  • Speaking & faculty fees$4,7503%
  • Grants$980%
  • Travel & lodging$50,07129%
  • Food & beverage$14,5758%
  • Education$1640%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$174,595 in reported general payments places this provider in the 95th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$123,209
Medicare patients
214
Services billed
3,464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl20$2,030
Gabapentin107$1,793
Pregabalin39$785
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$734
Duloxetine Hcl27$494
Tizanidine Hcl22$257
Methocarbamol16$145
Tramadol Hcl29$135
Meloxicam45$118
Methylprednisolone17$102

Paid to pharmacies, not to this prescriber.

Other pain medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →